Dyne Historical Financial Ratios
| DYN Stock | USD 27.68 1.07 3.72% |
Dyne TherapeuticsInc is recently reporting on over 90 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 9.13 or Days Sales Outstanding of 316 will help investors to properly organize and evaluate Dyne TherapeuticsInc financial condition quickly.
Dyne |
About Dyne Financial Ratios Analysis
Dyne TherapeuticsIncFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Dyne TherapeuticsInc investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Dyne financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Dyne TherapeuticsInc history.
Dyne TherapeuticsInc Financial Ratios Chart
Dyne TherapeuticsInc financial ratios usually calculated using numerical values taken directly from Dyne TherapeuticsInc financial statements such as income statements or balance sheets. They help investors to obtain meaningful information about Dyne TherapeuticsInc. Most financial ratios help to conduct quantitative analysis to assess vital information about the company's valuation as well as profitability and liquidity indicators such as leverage, growth, profit margins, and different types of rates of return.
At this time, Dyne TherapeuticsInc's PTB Ratio is very stable compared to the past year. As of the 20th of May 2024, PB Ratio is likely to grow to 9.13, while Price To Sales Ratio is likely to drop 6.54. Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Dyne TherapeuticsInc stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Dyne TherapeuticsInc sales, a figure that is much harder to manipulate than other Dyne TherapeuticsInc multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company’s stock price to its revenues, calculated by dividing the company’s market cap by its total sales or revenue over a 12-month period.Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Inventory Turnover
A ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management.Most ratios from Dyne TherapeuticsInc's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Dyne TherapeuticsInc current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dyne TherapeuticsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing. To learn how to invest in Dyne Stock, please use our How to Invest in Dyne TherapeuticsInc guide.At this time, Dyne TherapeuticsInc's PTB Ratio is very stable compared to the past year. As of the 20th of May 2024, PB Ratio is likely to grow to 9.13, while Price To Sales Ratio is likely to drop 6.54.
| 2023 | 2024 (projected) | Payables Turnover | 0.11 | 0.1 | Days Of Inventory On Hand | 49.86 | 48.73 |
Dyne TherapeuticsInc fundamentals Correlations
Click cells to compare fundamentals
Dyne TherapeuticsInc Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Dyne TherapeuticsInc fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Ptb Ratio | 77.34 | 0.88 | 1.64 | 2.39 | 8.7 | 9.13 | |
| Book Value Per Share | 0.31 | 23.78 | 7.23 | 4.86 | 1.53 | 1.45 | |
| Free Cash Flow Yield | (0.0124) | (0.16) | (0.2) | (0.26) | (0.24) | (0.23) | |
| Invested Capital | 4.44 | (0.69) | 0.0886 | 0.12 | 0.3 | 0.29 | |
| Operating Cash Flow Per Share | (0.26) | (3.23) | (2.35) | (2.96) | (3.15) | (2.99) | |
| Capex To Depreciation | (6.08) | (1.66) | (3.33) | (1.82) | (0.3) | (0.31) | |
| Pb Ratio | 77.34 | 0.88 | 1.64 | 2.39 | 8.7 | 9.13 | |
| Free Cash Flow Per Share | (0.3) | (3.31) | (2.42) | (3.02) | (3.16) | (3.01) | |
| Roic | (0.9) | (0.17) | (0.37) | (0.59) | (2.04) | (1.94) | |
| Net Income Per Share | (0.3) | (4.08) | (2.93) | (3.18) | (3.95) | (4.15) | |
| Payables Turnover | 0.22 | 0.2 | 0.27 | 0.64 | 0.11 | 0.1 | |
| Cash Per Share | 0.32 | 23.99 | 7.4 | 4.93 | 2.06 | 1.96 | |
| Pocfratio | (91.74) | (6.5) | (5.06) | (3.92) | (4.22) | (4.01) | |
| Capex To Operating Cash Flow | 0.14 | 0.025 | 0.0303 | 0.02 | 0.003874 | 0.003681 | |
| Pfcf Ratio | (80.53) | (6.34) | (4.91) | (3.84) | (4.2) | (3.99) | |
| Days Payables Outstanding | 1.7K | 1.8K | 1.4K | 573.85 | 3.4K | 3.6K | |
| Income Quality | 7.7 | 0.87 | 0.8 | 0.78 | 0.91 | 0.71 | |
| Roe | (0.96) | (0.17) | (0.41) | (0.65) | (2.58) | (2.46) | |
| Ev To Operating Cash Flow | (90.5) | (0.0315) | (3.65) | (3.0) | (3.72) | (3.53) | |
| Pe Ratio | (80.2) | (5.15) | (4.05) | (3.65) | (3.36) | (3.2) | |
| Return On Tangible Assets | (0.82) | (0.17) | (0.35) | (0.54) | (1.43) | (1.36) | |
| Ev To Free Cash Flow | (79.44) | (0.0307) | (3.55) | (2.94) | (3.7) | (3.52) | |
| Earnings Yield | (0.0125) | (0.19) | (0.25) | (0.27) | (0.3) | (0.28) | |
| Net Debt To E B I T D A | 1.0 | 5.13 | 1.13 | 0.83 | 0.39 | 0.37 | |
| Current Ratio | 6.26 | 31.49 | 13.31 | 9.11 | 2.53 | 4.74 | |
| Graham Number | 1.44 | 46.73 | 21.85 | 18.64 | 11.66 | 17.36 | |
| Shareholders Equity Per Share | 0.31 | 23.78 | 7.23 | 4.86 | 1.53 | 1.45 | |
| Debt To Equity | 4.44 | (0.69) | 0.0886 | 0.12 | 0.3 | 0.29 | |
| Capex Per Share | (0.0363) | (0.0806) | (0.0711) | (0.059) | (0.0122) | (0.0128) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dyne TherapeuticsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing. To learn how to invest in Dyne Stock, please use our How to Invest in Dyne TherapeuticsInc guide.You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Complementary Tools for Dyne Stock analysis
When running Dyne TherapeuticsInc's price analysis, check to measure Dyne TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dyne TherapeuticsInc is operating at the current time. Most of Dyne TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Dyne TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dyne TherapeuticsInc's price. Additionally, you may evaluate how the addition of Dyne TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |
Is Dyne TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dyne TherapeuticsInc. If investors know Dyne will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dyne TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.98) | Return On Assets (0.41) | Return On Equity (0.71) |
The market value of Dyne TherapeuticsInc is measured differently than its book value, which is the value of Dyne that is recorded on the company's balance sheet. Investors also form their own opinion of Dyne TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Dyne TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dyne TherapeuticsInc's market value can be influenced by many factors that don't directly affect Dyne TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dyne TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Dyne TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dyne TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.